IP Library Granted Patent US 10,478,464
Granted Patent B2
US 10,478,464 · App. 12/687,769 · Granted Nov 19, 2019

Compositions and methods of use

Inventors: Vipul C. Chitalia (Cambridge, MA); Daniel Prabakaran (Wayland, MA); Ajit Bharti (West Roxbury, MA); Gamini S. Jayatilake (Broomfield, CO); Xiong Fu (Superior, CO)
Assignee: Kirit Shah
A61K36/11A61K31/20A61K45/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,478,464
App. No.
12/687,769
Granted
Nov 19, 2019
Kind
B2
Abstract

This invention relates to the use of plant extracts, compositions thereof, and compounds isolated from plant extracts or obtained from synthetic means thereof, for the treatment of diseases, disorders or symptoms thereof (e.g., proliferation disorders, cancer).

Claims (13)

1. A method of treating cancer in a subject comprising administering to the subject a composition comprising an effective amount of 8-hydroxyhexadecanoic acid, or a salt thereof, thereby treating said cancer;

wherein said cancer is a lung cancer.

2. A method of treating cancer in a subject comprising administering to the subject a composition comprising an effective amount of 8-hydroxyhexadecanoic acid, or a salt thereof, thereby treating said cancer;

wherein said cancer is a lung cancer;

wherein said lung cancer is a non-small cell lung cancer.

3. A method of treating cancer in a subject comprising administering to the subject a composition comprising an effective amount of 8-hydroxyhexadecanoic acid, or a salt thereof, thereby treating said cancer;

wherein said cancer is a lung cancer;

wherein said lung cancer is mediated by HOP-92 or NCI-H460 cancer cells.

4. A method of treating cancer in a subject comprising administering to the subject a composition comprising an effective amount of 8-hydroxyhexadecanoic acid, or a salt thereof, thereby treating said cancer;

wherein said cancer is leukemia.

5. A method of treating cancer in a subject comprising administering to the subject a composition comprising an effective amount of 8-hydroxyhexadecanoic acid, or a salt thereof, thereby treating said cancer;

wherein said cancer is leukemia;

wherein said leukemia is mediated by CCRF-CEM, K-562, SR, MOLT-4, RPMI-8226, or HL-60(TB) cancer cells.

Assignments (3)
NOTICE OF ACCEPTANCE OF COLLATERAL Recorded Jul 3, 2018
From: VANAS ONCOLOGY INC.
To: SHAH, KIRIT, DR.
Reel/Frame 047111/0215 →
SECURITY INTEREST Recorded Sep 29, 2017
From: VANAS ONCOLOGY INC.
To: SHAH, KIRIT, DR.
Reel/Frame 043741/0282 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2010
From: JAYATILAKE, GAMINI S.; FU, XIONG; CHITALIA, VIPUL C.; PRABAKARAN, DANIEL; BHARTI, AJIT
To: VANAS ONCOLOGY
Reel/Frame 024187/0529 →
Continuity (2)
Provisional Application 61205144 · Jan 14, 2009
Related Publication 20100209543A1 · Aug 19, 2010